Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119053617A reveals mixed phase synthesis for dual agonists. Enhances purity and yield for reliable pharmaceutical intermediates supplier partnerships globally.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN112125970A reveals a novel solid-phase synthesis for Semaglutide using specialized Asp protection and fragment condensation to enhance yield and purity for reliable API manufacturing.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Patent CN102875665A reveals a high-yield fragment condensation method for Liraglutide, offering superior purity and cost-effective manufacturing alternatives to recombinant technologies.
Patent CN103864918A reveals efficient fragment condensation for liraglutide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Novel Fmoc solid-phase route for Telaprevir reduces cost and complexity. High purity API intermediate manufacturing solution for global supply chains.
Novel solid-phase synthesis of Goserelin avoids palladium reduction. Enhances purity and supply chain reliability for pharmaceutical manufacturing partners globally.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN101899092A reveals a novel solid-phase method for peptide-linker-oligonucleotide conjugates, enhancing cell permeability and simplifying manufacturing for reliable supply.
Novel segment condensation method enhances thymalfasin purity and reduces impurities for scalable pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN115991738A details a novel solid-phase synthesis for Plecanatide using orthogonal S-Tmp and Acm protection, ensuring high purity and commercial scalability for pharmaceutical manufacturers.
Patent CN106854235B reveals a novel solid-phase fragment method for Carbetocin, offering high purity and reduced solvent waste for pharmaceutical manufacturing.
Patent CN113801199B details novel Mitsunobu cyclization for carbetocin. Enhances purity and yield while reducing manufacturing costs for reliable supply chains.
Patent CN106892968B reveals a novel selective oxidation strategy for Linaclotide. Achieve high purity and yield with our scalable peptide manufacturing solutions.
Patent CN110642936A details a high-yield fragment condensation method for teriparatide, offering superior purity and cost-effective manufacturing for global supply chains.
Advanced solid-phase synthesis of Somaglutide via CN108359006B ensures high purity and yield. Discover cost-effective scalable manufacturing for global supply chains.
Patent CN104311639B details advanced solid-phase synthesis for somatostatin. Achieve higher purity and yield with optimized temperature control and resin selection.